Cystic Fibrosis

Research in cystic fibrosis focuses on understanding the underlying molecular and cellular mechanisms of the disease. Investigations explore how mutations in the CFTR gene lead to protein misfolding, impaired ion transport, and the resulting chronic lung infections, inflammation, and organ damage. Studies employ various approaches, including genetic analysis, cell culture models, and animal models, to investigate disease progression and identify potential therapeutic targets. Areas of focus include developing new drug therapies, improving existing treatments, and understanding the impact of CFTR dysfunction on other organ systems.

This work is relevant to Arkansas's public health by addressing the needs of individuals living with cystic fibrosis within the state. Understanding disease mechanisms and treatment effectiveness can inform clinical care and public health initiatives aimed at improving outcomes for Arkansas patients. Furthermore, research into genetic disorders has broader implications for understanding inherited conditions prevalent in the state's population.

This research area intersects with studies in metabolism, genetic disorders, health disparities, child and adolescent health, and pharmacology. Connections are also made with disease modeling, organ transplantation, and drug resistance mechanisms. Engagement spans multiple disciplines to provide a comprehensive approach to cystic fibrosis research.